key: cord-0959163-28pzdehe authors: Jafari, Ramezan; Cegolon, Luca; Masghsoudi, Houshyar; Zhao, Shi; Fathi, Saeid; Khedmat, Leila; Javanbakht, Mohammad title: Giant cavity pulmonary lesion and pneumothorax simultaneously following COVID-19 pneumonia date: 2021-06-14 journal: Radiol Case Rep DOI: 10.1016/j.radcr.2021.06.026 sha: 9691b9fc74033bb134e3864cad8da21d4b5b19da doc_id: 959163 cord_uid: 28pzdehe Cavitary lung formation with spontaneous pneumothorax has been rarely reported as a complication of COVID-19 pneumonia. We report a rare case of a 38 years-old male patient affected by COVID-19 pneumonia, exceptionally complicated by a simultaneous giant cavity in the right upper lung and a small right pneumothorax in the right hemithorax. Whilst pneumothorax emphysema, giant bullae and pneumothorax with alveolar rupture are known to potentially develop in COVID-19 patients as a result of high-flow O(2) support, the exact origin of the giant lung cavitation in our patient could be not confirmed. Cavitary lesions – featured by high mortality rate - are reportedly associated with lung infarctions and can be the aftermaths of pulmonary embolism, a rather common sequela of COVID-19 pneumonia. Radiological imaging is critical to support clinical decision making in the management of COVID-19 pneumonia, since not only it can visualize and stage the disease, but it can also detect and monitor the eventual onset of complications over time, even following patient discharge from hospital. COVID-19 can present in various manifestations and computed tomographic (CT) imaging plays an critical role in diagnosing the stages of pneumonia caused by SARS-CoV-2 [1] . Idiopathic cavitary pulmonary lesions and pneumothorax are rare complications reportedly affecting a small proportion of COVID-19 patients [2] [3] [4] [5] [6] , Herein, we report a 38 years old male patient affected by COVID-19 pneumonia, developing simultaneous lung cavitation and pneumothorax. On February 25, a 38-year-old-male patient presented to accident & emergency service (A&E) of Baqiyatallah hospital in Tehran (Iran) for fever (38˚C), complaining shortness of breath, chilling and malaise during the preceding 4 days. The patient had no relevant medical history. Baseline O 2 saturation at admission was 85%, increasing up to 92% following O 2 supplementation. Laboratory tests showed a white blood cell count of 10,200/mm 3 with 6.2% lymphocytes. The erythrocyte sedimentation rate (ESR= 84 mm/h) and the C reactive protein A Spiral multi-slice chest CT scan, performed on the same day of A&E admission, showed bilateral multilobar patchy ground glass opacity (GGOs) and consolidative lung opacities (CLO) with peripheral lung distribution (Fig 1A) , a radiological pattern compatible with COVID-19 pneumonia. The patient was treated with oral hydroxychloroquine sulfate 200mg twice a day, oral oseltamivir 75 mg twice a day, palliative therapy and O 2 supplements. After 10 days of the latter treatment regimen, the WBC count decreased to 4,90/mm3 and the lymphocyte rate increased up to 24%. The ESR (95 mm/h) and CRP (115 mg/L) were still both elevated. The O 2 saturation increased to 89% without respiratory support and the patient's symptoms improved. As the patient's health conditions were progressively improving, a follow-up spiral chest computerized tomography (CT) scan, performed after 10 days since hospital admission, showed a significant reduction of the CLO and GGOs. However, the CT scan also revealed a giant cavity of about 40mm diameter, with a thick irregular wall in the right upper lung and a small pneumothorax in the right hemithorax (Fig, 1B) . Classic COVID-19 pneumonia presents with GGO and CLO, predominantly in the lower lung lobes, without cavitary lesions, pneumothorax, lymphadenopathy and pleural effusion [3, 4, 7, 8] . Complications of COVID-19 pneumonia can still arise over time and cavitary lung lesions (also of gigantic size) as well as pneumothorax have also been reported [2, 4, [9] [10] [11] [12] [13] . Nevertheless, a simultaneous pneumothorax as well as cavitary lung formation is an exceptional and idiopathic feature. Spontaneous pneumotorax can be a late evolution of COVID-19 pneumonia [14] , although a bilateral sudden onset was also described in a 50 year old male smoker with history of mandibular carcinoma [15] . Emphysema, giant bullae and pneumothorax with alveolar rupture can develop in COVID-19 patients as a result of high-flow O 2 support [12 ] . By contrast, pulmonary cavitary lesions are usually associated with mycobacterial diseases, fungal or parasitic infections, malignancies or autoimmune disorders [16, 17] . Although the exact origin of the giant lung cavitation in our patient was not confirmed, diffuse alveolar damage, intra-alveolar haemorrhage and parenchymal necrosis associated with COVID-19 pneumonia can be explanatory factors [18, 19] . Furthermore, cavitary lesions are reported in 4-7% lung infarctions and can be the aftermaths of pulmonary embolism, a rather common complication of COVID-19 pneumonia [20, 21] . High mortality rates are reported with cavitations associated with pulmonary infarctions, whether infected or not [22] . Radiological imaging is therefore critical to support clinical decision making in the management of COVID-19 pneumonia, since not only it can visualize and stage the but it can also detect and monitor the eventual onset of complications over time, even following patient discharge from hospital Diagnostic imaging in COVID-19 pneumonia: a literature review Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease Large pulmonary cavity in COVID-19 cured patient case report Lung cavitation due to COVID-19 pneumonia COVID-19 and pneumothorax: a multicentre retrospective case series Case Report: COVID-19-Associated Bilateral Spontaneous Pneumothorax-A Literature Review Ct imaging features of 2019 novel coronavirus (2019-nCoV) Lobar distribution of COVID-19 pneumonia based on chest computed tomography findings; a retrospective study Cavitary lung lesions and pneumothorax in a healthy patient with active coronavirus-19 (COVID-19) viral pneumonia Pulmonary infarctions as the cause of bilateral cavitations in a patient with COVID-19 Pulmonary Embolism and Giant Cavitary Lesion Developing After COVID-19 Pneumonia An unusual cause of spontaneous pneumothorax: Post-COVID-19 pulmonary fibrosis COVID-19 pneumonia complicated by bilateral pneumothorax: A case report An unusual presentation of pulmonary embolism leading to infarction, cavitation, abscess formation and bronchopleural fistulation Acute pulmonary embolism leading to cavitation and large pulmonary abscess: a rare complication of pulmonary infarction Post-Mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction A pathological report of three COVID-19 cases by minimal invasive autopsies Pul-monary cavitation following pulmonary infarc-tion Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease All authors contributed equally to the drafting, designing and writing of the manuscript and provided critical revision. All authors read and approved the final manuscript Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.